SEC CIK 1161662
RIEDEL NORBERT G
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BAXview stock → | 58,614 | 2013-01-16 |
| JAZZview stock → | 6,923 | 2026-08-31 |
Position History — JAZZ
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — JAZZ
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-08-31 | Tax withholding | 1,692 | $241.39 | 6,923 |
| 2026-08-31 | Tax withholding | 14 | $244.64 | 8,615 |
| 2026-08-05 | Grant / award | 1,605 | $0.00 | 8,629 |
| 2026-02-27 | Option exercise (derivative) | 3,415 | $0.00 | 0 |
| 2026-02-27 | Open-market sale | 3,415 | $192.00 | 7,024 |
| 2026-02-27 | Option exercise | 3,415 | $138.08 | 10,439 |
| 2025-08-08 | Tax withholding | 1,805 | $111.25 | 7,024 |
| 2025-08-07 | Grant / award | 3,507 | $0.00 | 8,829 |
| 2024-08-06 | Tax withholding | 1,484 | $111.35 | 5,322 |
| 2024-08-02 | Grant / award | 3,731 | $0.00 | 6,806 |
| 2023-08-14 | Open-market sale | 1,241 | $138.16 | 13,705 |
| 2023-08-11 | Grant / award | 3,075 | $0.00 | 14,946 |
| 2022-08-08 | Open-market sale | 1,089 | $152.32 | 11,871 |
| 2022-08-05 | Option exercise (derivative) | 8,000 | $0.00 | 0 |
| 2022-08-05 | Open-market sale | 8,000 | $155.87 | 10,399 |
| 2022-08-05 | Grant / award | 2,561 | $0.00 | 12,960 |
| 2022-08-05 | Option exercise | 8,000 | $55.28 | 18,399 |
| 2021-08-06 | Open-market sale | 1,306 | $147.96 | 10,399 |
| 2021-07-29 | Grant / award | 2,246 | $0.00 | 11,705 |
| 2020-08-07 | Open-market sale | 931 | $125.87 | 9,459 |
| 2020-08-06 | Grant / award (derivative) | 6,765 | $0.00 | 6,765 |
| 2020-08-06 | Grant / award | 2,705 | $0.00 | 10,390 |
| 2019-08-09 | Open-market sale | 726 | $135.65 | 7,685 |
| 2019-08-08 | Grant / award (derivative) | 4,805 | $0.00 | 4,805 |
| 2019-08-08 | Grant / award | 1,920 | $0.00 | 8,411 |
| 2018-08-10 | Open-market sale | 660 | $176.61 | 6,491 |
| 2018-08-09 | Grant / award (derivative) | 3,735 | $0.00 | 3,735 |
| 2018-08-09 | Grant / award | 1,495 | $0.00 | 7,151 |
| 2017-08-11 | Open-market sale | 3 | $144.13 | 5,656 |
| 2017-08-11 | Open-market sale | 659 | $142.36 | 5,659 |
| 2017-08-10 | Grant / award (derivative) | 3,415 | $0.00 | 3,415 |
| 2017-08-10 | Grant / award | 1,365 | $0.00 | 6,318 |
| 2016-08-15 | Open-market sale | 633 | $136.45 | 4,953 |
| 2016-08-11 | Grant / award (derivative) | 3,415 | $0.00 | 3,415 |
| 2016-08-11 | Grant / award | 1,365 | $0.00 | 5,586 |
| 2016-05-16 | Open-market sale | 644 | $145.20 | 4,221 |
| 2015-08-10 | Open-market sale | 797 | $179.98 | 4,869 |
| 2015-08-10 | Open-market sale | 4 | $183.36 | 4,865 |
| 2015-08-07 | Grant / award (derivative) | 3,415 | $0.00 | 3,415 |
| 2015-08-07 | Grant / award | 1,310 | $0.00 | 5,666 |
| 2015-05-12 | Open-market sale | 6 | $175.10 | 4,356 |
| 2015-05-12 | Open-market sale | 644 | $173.85 | 4,362 |
| 2014-08-07 | Grant / award (derivative) | 3,300 | $0.00 | 3,300 |
| 2014-08-07 | Grant / award | 1,650 | $0.00 | 5,006 |
| 2014-05-28 | Open-market sale | 644 | $142.49 | 3,356 |
| 2013-05-09 | Grant / award (derivative) | 8,000 | $0.00 | 8,000 |
| 2013-05-09 | Grant / award | 4,000 | $0.00 | 4,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.